Publications

Mahana is committed to developing safe and effective products. Below are links to peer-reviewed publications for Parallel1, our IBS treatment.

Assessing telephone-delivered cognitive–behavioural therapy (CBT) and web-delivered CBT versus treatment as usual in irritable bowel syndrome (ACTIB): a multicentre randomised trial

Everitt HA, Landau S, O’Reilly G on behalf of ACTIB trial group, et al.

October 2018

Exploring Patients' Views of a Cognitive Behavioral Therapy-Based Website for the Self-Management of Irritable Bowel Syndrome Symptoms

Tonkin-Crine, S. Bishop, F.L. Ellis, M. Moss-Morris, R. and Everitt, H.

September 2013

Management of irritable bowel syndrome in primary care: feasibility randomised controlled trial of mebeverine, methylcellulose, placebo and a patient self-management cognitive behavioural therapy ...

Everitt, H.A. Moss-Morris, R. Sibelli, A. Tapp, L. Coleman, N.S. Yardley, L. Smith, P.W. and Little

November 2010

Assessing Cognitive behavioural Therapy in Irritable Bowel (ACTIB): protocol for a randomised controlled trial of clinical-effectiveness and cost-effectiveness of therapist delivered cognitive behavioural ...

Everitt, H. Landau, S. Little, P. Bishop, F.L. McCrone, P. O’Reilly, G. Coleman, N. Logan, R. Chalder, T. Moss-Morris, R. (2015)

July 2015

Interested in our clinical trial?

If you're a qualified healthcare professional interested in participating in a Mahana clinical trial, contact our Clinical Team.

Get in Touch

1 Parallel, formerly known as Regul8, originally was developed by Rona Moss-Morris Ph.D, Head of Psychology Department, King’s College London (KCL) in collaboration with Trudie Chalder, Ph.D, Professor of Cognitive Behavioural Psychotherapy and Alice Sibelli, Ph.D. at KCL and Dr. Hazel Everitt, Professor of Primary Care Research, University of Southampton. Initial clinical funding support was provided by the UK National Institute for Health Research (NIHR)